Gemini is a free chatbot, search companion and more. Here's what you need to know about Google's AI tool. Barbara is a tech writer specializing in AI and emerging technologies. With a background ...
Researchers found the Hospital Anxiety and Depression Scale (HADS) to be a useful tool for anxiety assessment in routine COPD management.
The National Institute for Health and Care Excellence (NICE) is producing an Early Value Assessment on Digital technologies for Digital technologies to support self-management of COPD in the NHS in ...
This was a single-center, prospective study. Patients with COPD were included if their post-bronchodilator forced expiratory volume in 1 s (FEV 1)/forced vital capacity ratio was <0.7 and FEV 1 ...
Dupixent was associated with a 30 and 34 percent reduction in the annualized rate of moderate or severe COPD exacerbations over 52 weeks (the primary end point) versus placebo. Greater ...
The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with poorly controlled chronic obstructive pulmonary disease (COPD) and high ...
While AI's role in clinical trial design and real-time monitoring is well-known, it also brings unprecedented potential in reshaping health economics and its assessment models. AI-driven tools can ...
Dupixent is now cleared for use as an add-on maintenance treatment for adults with a certain kind of chronic obstructive pulmonary disease, or COPD, that can’t be controlled with other medications.
Over the last decade, as other companies—such as AstraZeneca with IL-5 inhibitor Fasenra—struggled to advance candidates for COPD, Regeneron and Sanofi took a more “phenotype-driven approach ...
This approval was based on results from the phase 3 BOREAS (NCT03930732) and NOTUS (NCT04456673) trials, which demonstrated that dupilumab can significantly reduce COPD exacerbations. 2 The first ...
The drug was cleared for use in adults whose COPD symptoms aren’t under control and whose disease is driven by eosinophils, a type of immune cell that can contribute to inflammation. There are ...
As someone who's just wrapped up a masters degree, I can't help but feel a twinge of envy at the latest AI tools hitting the market. AI has improved in leaps and bounds in the last year ...